Difference between revisions of "Phage therapy"
Jump to navigation
Jump to search
→Experiments and Anticipated Problems
| Line 35: | Line 35: | ||
== Experiments and Anticipated Problems == | == Experiments and Anticipated Problems == | ||
:We plan to begin acquiring clinical samples in April, 2013. Samples will be grown on Modified Thayer Martin agar supplemented with antibiotics. Colonies will '''(1)'''be stored in glycerol at -80oC, '''(2)'''grown in liquid culture for the assessment of bacteriophage production, '''(3)'''grown in Maltose to ensure we have cultured ''N. gonorrhoeae,'' and '''(4)'''grown in Fastidious Broth with 3rd-generation antibiotics to assess antibiotic resistance. | |||
: | : | ||
:Following growth in FB, supernatants will be analyzed for the presence of bacteriophage using SDS-PAGE electrophoresis. | |||
:If bacteriophage proteins are present in the supernatants, these cultures will be re-grown in bulk and bacteriophage-containing sups will be stored at -80oC. | |||
== Laboratory Needs == | == Laboratory Needs == | ||